New drug tested for Life-Threatening immune storms
NCT ID NCT05001737
Summary
This study tested a drug called emapalumab in children and adults with a dangerous immune system overreaction called Macrophage Activation Syndrome (MAS). MAS can occur in people with Still's disease or lupus who don't respond well to high-dose steroid treatment. The trial aimed to see if emapalumab could control this severe condition and reduce the need for steroids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akron Children's Hospital
Akron, Ohio, 44308, United States
-
Alberta Children's Hospital
Calgary, Canada
-
Beijing Children's Hospital
Beijing, China
-
Beijing Friendship Hospital
Beijing, China
-
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Canada
-
Centre Hospitalier de l'Université de Montréal
Montreal, Canada
-
Charité Universitätsmedizin
Berlin, Germany
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30329, United States
-
Children's Hospital of Fudan University
Shanghai, China
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Fakultní nemocnice Olomouc
Olomouc, Czechia
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
-
Great Ormond Street Hospital
London, United Kingdom
-
Hospital Sant Joan de Déu
Barcelona, Spain
-
Hospital Universitari i Politècnic La Fe
Valencia, Spain
-
Hospital Universitario
La Paz, Spain
-
Hospital Universitario La Paz
La Paz, Spain
-
Hospital for sick children
Toronto, Canada
-
Hôpital Claude Huriez
Lille, France
-
Hôpital De La Conception
Marseille, France
-
Hôpital Necker-Enfants Malades
Paris, France
-
Hôpital Universitaire Pitié Salpêtrière
Paris, France
-
IRCCS - Materno-Infantile Burlo Garofolo
Trieste, Italy
-
IRCCS G. Gaslini
Genova, Italy
-
Imperial College Healthcare NHS Trust
London, United Kingdom
-
Nationwide Children's Hospital, Abigail Wexner Research Institute
Columbus, Ohio, 43205, United States
-
Ortopedyczno - Rehabilitacyjny Szpital Kliniczny im. Wiktora Degi Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu
Poznan, Poland
-
Osaka Medical and Pharmaceutical University Hospital
Takatsuki, Japan
-
Ospedale Pediatrico Bambino Gesù
Roma, Italy
-
St. Marianna University School of Medicine Hospital
Kawasaki, Japan
-
Szpital Specjalistyczny im. J. Dietla w Krakowie
Krakow, Poland
-
Tokyo Medical and Dental University Hospital
Tokyo, Japan
-
UAB Hospital
Birmingham, Alabama, 35233, United States
-
UCLA Health
Los Angeles, California, 90095, United States
-
UMC Utrecht
Utrecht, Netherlands
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
-
Universitair Ziekenhuis Leuven
Leuven, Belgium
-
University of Calgary
Calgary, Canada
-
University of Florida
Gainesville, Florida, 32610, United States
-
University of Minnesota Masonic Children's Hospital
Minneapolis, Minnesota, 55455, United States
-
Universitätsklinikum Heidelberg
Heidelberg, Germany
-
Vseobecna Fakultni Nemocnice v Praze
Prague, Czechia
-
Wojewódzki Specjalistyczny Szpital Dziecięcy im. św. Ludwika w Krakowie
Krakow, Poland
-
Yokohama City University Hospital
Yokohama, Japan
Conditions
Explore the condition pages connected to this study.